Sueta, Aiko
Yamamoto-Ibusuki, Mutsuko
Tomiguchi, Mai
Fujiki, Yoshitaka
Goto-Yamaguchi, Lisa
Iwase, Hirotaka
Yamamoto, Yutaka http://orcid.org/0000-0001-6147-6828
Article History
Received: 1 September 2021
Accepted: 28 November 2021
First Online: 5 January 2022
Declarations
:
: Y. Yamamoto has relevant conflicts of interest, as follows: personal fees from Chugai, AstraZeneca, Kyowa-Kirin, Pfizer, Novartis, Essai, Takeda, Taiho, GE Health Care Japan, Nippon Kayaku, Daiichi-Sankyo, Sysmex, and Lilly; grants from Chugai, Pfizer, AstraZeneca, Kyowa-Kirin, Daiichi-Sankyo, Nippon Kayaku, and Lilly.The other authors have no conflicts of interest to declare.
: The entire study was approved by the ethics committee of Kumamoto University Graduate School of Medical Sciences.
: Written informed consent was obtained from all subjects for the collection and research use of serum samples. All relevant methods were performed according to the relevant guidelines and regulations.
: Not applicable.